Beckman’s year of uncertainty continues as it looks to strategic options
This article was originally published in Clinica
It has not been a vintage year for biomedical test and lab systems manufacturer Beckman Coulter, and may even be the last one under its current ownership structure, if reports in mid-month are to be believed.
You may also be interested in...
The MHRA has been working all hours to ensure the standalone medtech UKCA mark works operationally and procedurally in the UK as of 1 January 2021.
Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.